PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1381674
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1381674
Global Kyphoplasty Market is valued approximately USD 633.3 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2023-2030. Kyphoplasty is a medical procedure used to treat vertebral compression fractures, which are fractures in the bones of the spine (vertebrae) that result in a collapse or loss of height of the affected vertebra. These fractures can be caused by conditions such as osteoporosis, spinal tumors, or trauma. Kyphoplasty is primarily performed to relieve pain caused by vertebral compression fractures, stabilize the spine, and improve the patient's mobility and quality of life. The Kyphoplasty market is expanding because of factors such as the rising prevalence of osteoporosis worldwide and the rising Geriatric Population.
According to a study published in the journal Frontiers in Endocrinology in May 2022, 200 million women globally have osteoporosis. The incidence of hip fractures was predicted to rise by 240% for women and 310% for men globally by 2050. The same study stated that adults who already have one form of fracture are 50% to 100% more likely to get a different type of fracture, independent of the type and that practically all types of fractures increase in patients with low bone mineral density. This demonstrates that the most severe result of osteoporosis is a fracture and that the rising incidence of osteoporosis will ultimately spur market growth. Furthermore, according to the United Nations Department of Economics and Social 2022 research, which predicts that 771 million people would be 65 or older worldwide in 2022, the senior population will increase to 994 million by 2030 and 1.6 billion by 2050. Therefore, it is projected that the need for kyphoplasty would increase with the expanding senior population due to the loss of bone mass that occurs as part of aging in the elderly. In addition, increasing advancements in technology and increasing health expenditure are creating new opportunities for the market. However, the stringent regulatory framework and availability of alternative treatments stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Kyphoplasty Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising disease prevalence, rising favorable government reimbursement policies, and rising development of new products and healthcare expenditure in the region. Whereas, Asia Pacific is projected to grow at the fastest pace owing to factors such as a rising geriatric population, rising prevalence of various diseases, rising number of partnerships and coloration of product development activities, and rising healthcare expenditure in the region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable